Clinical Trials Browser

Phase 1/2 × MAGEA3 protein, human × Dermatologic × Clear all

NCT00074230 2015-05-12

Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

Phase 1/2 Completed

Melanoma

NCT00002952 2013-09-05

Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Melanoma